Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: a multicenter retrospective study

Response Rate ◽

Complete Response Rate ◽

Standard Dose ◽

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study

Cancer Management and Research ◽

10.2147/cmar.s298360 ◽

2021 ◽

Vol Volume 13 ◽

pp. 2163-2170

Author(s):

Wen Zhang ◽

Yong Li ◽

Liyan Xue ◽

Dong Qu ◽

Zhichao Jiang ◽

...

Keyword(s):

Retrospective Study ◽

Response Rate ◽

Complete Response Rate ◽

Locally Advanced ◽

Squamous Carcinoma ◽

Complete Response ◽

Esophageal Squamous Carcinoma

Pathological complete response rate in hormone receptor-negative breast cancer treated with neoadjuvant FEC, followed by weekly paclitaxel administration: A retrospective study and review of the literature

Oncology Letters ◽

10.3892/ol.2016.4334 ◽

2016 ◽

Vol 11 (5) ◽

pp. 3064-3070

Author(s):

TAKAYOSHI KIBA ◽

NAO MORII ◽

HIROTOSHI TAKAHASHI ◽

SHINJI OZAKI ◽

MISAO ATSUMI ◽

...

Keyword(s):

Breast Cancer ◽

Retrospective Study ◽

Hormone Receptor ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Weekly Paclitaxel ◽

Review Of The Literature

Prognostic Function of Ki-67 for Pathological Complete Response Rate of Neoadjuvant Chemotherapy in Triple-negative Breast Cancer

Tumori Journal ◽

10.1177/030089161410000204 ◽

2014 ◽

Vol 100 (2) ◽

pp. 136-142 ◽

Cited By ~ 3

Author(s):

Guojing Zhang ◽

Wanqing Xie ◽

Zhaozhe Liu ◽

Chao Lin ◽

Ying Piao ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Ki 67

Unfavorable pathological complete response rate of neoadjuvant chemotherapy epirubicin plus taxanes for locally advanced triple-negative breast cancer

Journal of Huazhong University of Science and Technology [Medical Sciences] ◽

10.1007/s11596-013-1108-9 ◽

2013 ◽

Vol 33 (2) ◽

pp. 262-265 ◽

Cited By ~ 4

Author(s):

Yi Yin ◽

Pin Zhang ◽

Bing-he Xu ◽

Bai-lin Zhang ◽

Qing Li ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Locally Advanced ◽

Is Pathological Complete Response Rate Associated with Improved Local Control in Localized Triple Negative Breast Cancer After Neoadjuvant Chemotherapy?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2017.06.600 ◽

2017 ◽

Vol 99 (2) ◽

pp. E4

Author(s):

T. Biswas ◽

J.T. Efird ◽

S. Prasad ◽

S.E. James ◽

T.M. Zagar

Keyword(s):

Breast Cancer ◽

Local Control ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Clinical tumor stage is the most important predictor of pathological complete response rate after neoadjuvant chemotherapy in breast cancer patients

Breast Cancer Research and Treatment ◽

10.1007/s10549-017-4155-2 ◽

2017 ◽

Vol 163 (1) ◽

pp. 83-91 ◽

Cited By ~ 21

Author(s):

Briete Goorts ◽

Thiemo J. A. van Nijnatten ◽

Linda de Munck ◽

Martine Moossdorff ◽

Esther M. Heuts ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Tumor Stage ◽

Important Predictor ◽

Breast Cancer Patients

Luminal androgen receptor role and pathological complete response rate to neoadjuvant chemotherapy in triple negative breast cancer

Annals of Oncology ◽

10.1093/annonc/mdw364.43 ◽

2016 ◽

Vol 27 ◽

pp. vi55 ◽

Cited By ~ 1

Author(s):

M.R. Chica-Parrado ◽

A. Santonja ◽

A. Lluch-Hernandez ◽

J. Albanell ◽

A. Sanchez-Muñoz ◽

...

Keyword(s):

Breast Cancer ◽

Androgen Receptor ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

A significant correlation between pathological complete response rate in breast and axilla after neoadjuvant chemotherapy in 109 breast cancer patients

The Breast ◽

10.1016/s0960-9776(19)30266-8 ◽

2019 ◽

Vol 44 ◽

pp. S71-S72

Author(s):

K. Chin ◽

J. Grip Linden ◽

A. Kovacs ◽

Z. Einbeigi ◽

K. Larsson ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Response Rate ◽

Complete Response Rate ◽

Complete Response ◽

Breast Cancer Patients

Bevacizumab in neoadjuvant chemotherapy increases the pathological complete response rate in patients with triple-negative breast cancer

CA A Cancer Journal for Clinicians ◽

10.3322/caac.21223 ◽

2014 ◽

Vol 64 (3) ◽

pp. 155-156 ◽

Cited By ~ 6

Author(s):

Mary Kay Barton

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy

Oncotarget ◽

10.18632/oncotarget.25413 ◽

2018 ◽

Vol 9 (41) ◽

pp. 26406-26416 ◽

Cited By ~ 36

Author(s):

Angela Santonja ◽

Alfonso Sánchez-Muñoz ◽

Ana Lluch ◽

Maria Rosario Chica-Parrado ◽

Joan Albanell ◽

...

Keyword(s):

Breast Cancer ◽

Triple Negative ◽

Response Rate ◽

Complete Response Rate ◽

Pathologic Complete Response ◽

Complete Response ◽

Cancer Subtypes ◽

Pathologic Complete Response Rate